# Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

> **NCT00665327** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 401 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Avelox (Moxifloxacin, BAY12-8039)
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT00665327
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665327, "Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00665327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*